General
Preferred name
selegiline
Synonyms
SELEGILINE HYDROCHLORIDE ()
R(-)-Deprenyl hydrochloride ()
(R)-(-)-Deprenyl hydrochloride ()
R-(-)-Deprenyl hydrochloride ()
L-deprenyl-D2 C-11 ()
Ensam ()
Stilline 10 ()
Zelapar ()
Centrapryl 10 ()
L-Deprenyl ()
Eldepryl ()
Stilline 5 ()
Selegiline HCl ()
NSC-759259 ()
Vivapryl ()
Centrapryl 5 ()
EMSAM ()
L-selegiline ()
R-(?)-Deprenyl (hydrochloride) ()
P&D ID
PD013116
CAS
14611-51-9
102741-42-4
14611-52-0
Tags
covalent binder
drug candidate
natural product
drug
available
Approved by
FDA
First approval
1989
Drug Status
investigational
approved
vet_approved
Drug indication
Chemotherapy-induced nausea
Antidyskinetic
Motor symptoms
Major depressive disorder
Skin imperfections
Parkinson disease
Antiparkinsonian (in combination with levodopa/carbidopa)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Marketed formulations may contain (PubChem CID 26758). (GtoPdb)
DESCRIPTION Adenylyl cyclase activator (Tocris Bioactive Compound Library)
Compound Sets
28
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CovalentInDB
Drug Repurposing Hub
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
Enamine BioReference Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
73
Properties
(calculated by RDKit )
Molecular Weight
187.14
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
1
Aromatic Ring Count
1
cLogP
2.18
TPSA
3.24
Fraction CSP3
0.38
Chiral centers
1.0
Largest ring
6.0
QED
0.65
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Neuroscience
Target
MAO-B
MAOA, MAOB
MAO-B inhibitor
Primary Target
Monoamine Oxidases
MOA
MAO
Inhibitor
MAO-B Inhibitors
monoamine oxidase inhibitor
Member status
virtual
Indication
Parkinson's Disease
Therapeutic Class
Neurology Agents
Source data